Michael R Hayden

16PUBLICATIONS

49CO-AUTHORS

Epigenetics (incl. genome methylation and epigenomics)Gene and molecular therapyCardiology (incl. cardiovascular diseases)Autonomic nervous systemNeurogenetics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (16)

Sort by Publication Date:

|May 27, 2026

Clinical implications of loss of interruption variants for diagnosis, genetic counselling, and clinical trials in Huntington's disease.

|Jan 22, 2026

Silencing of human <i>HTT</i> by targeted CRISPR/dCas9-mediated epigenetic editing.

Yi Lin Tay, Sarah B Thomson, Silvia Hnatova

|Jan 09, 2026

Treatment of Huntington's disease with a pan-HTT-targeting CRISPR nuclease.

Katherine Tan, Daniela Del Bosque Siller, Alisha Y Xiong

|Dec 31, 2025

Pridopidine, a Potent and Selective Therapeutic Sigma-1 Receptor (S1R) Agonist for Treating Neurodegenerative Diseases.

Noga Gershoni Emek, Andrew M Tan, Michal Geva

|Dec 19, 2025

Sequence Variants in Small CAG Repeat Expansions of the <i>HTT</i> Gene and Disease Onset and Progression in Huntington Disease.

Anna Heinzmann, Emilien Petit, Jessica Dawson

|Mar 27, 2025

Optimization of adeno-associated viral (AAV) gene therapies vectors for balancing efficacy, longevity and safety for clinical application.

Neel Mehta, Rénald Gilbert, Parminder S Chahal

Pageof 3

Frequent Collaborators

Emily M Harvey

Lynn A Raymond

Luana Naia

Teresa Cunha-Oliveira

Joana Rodrigues

Tatiana R Rosenstock

Ana Oliveira

Catarina Carmo

Kyla Javier

A Cristina Rego

Frequent Collaborators

Emily M Harvey

Lynn A Raymond

Luana Naia

Teresa Cunha-Oliveira